4//SEC Filing
Sullivan Christopher Ryan 4
Accession 0001628280-23-003708
CIK 0001534120other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:19 PM ET
Size
5.6 KB
Accession
0001628280-23-003708
Insider Transaction Report
Form 4
Sullivan Christopher Ryan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-13+40,000→ 40,000 totalExercise: $2.98Exp: 2033-02-13→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001810417
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:19 PM ET
- Size
- 5.6 KB